InsiderTrades

Form 4/A for ANIP ANI PHARMACEUTICALS INC

Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-14 · accession 0001870913-23-000016 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MAI 2023-11-20 2023-11-14+ ANIP Shanmugam Muthusamy HEAD OF R, D, COO-NOVITIUM OPS, Dir S - Sale $53.00 -37.0K 995.6K -4% -$1.96M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-14 S D 22,905 $53.17 1,009,715 I Held by Esjay LLC — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.95 to $54.07, inclusive. (F3) The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.
2 Common Common Stock 2023-11-15 S D 7,647 $53.64 1,002,068 I Held by Esjay LLC — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.96 to $54.24, inclusive. (F3) The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.
3 Common Common Stock 2023-11-16 S D 6,448 $51.66 995,620 I Held by Esjay LLC — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $51.14 to $52.70, inclusive (F3) The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.